Physician profile
Ellen A Thompson
NPI 1740240936
$5,505.05
in general payments reported to CMS, 2019-2025
21 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $44.22 · 2021: $260 · 2022: $547 · 2023: $1,407 · 2024: $1,661 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,322.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $948.04 | 2023-2025 | Ffrct |
| Novartis Pharmaceuticals Corporation | $788.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $613.80 | 2022-2025 | Farxiga, Lokelma, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $593.78 | 2019-2025 | Lifevest |
| Abbott Laboratories | $474.26 | 2023-2025 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.52 | 2021-2024 | Jardiance |
| Amgen INC. | $219.69 | 2021-2024 | Repatha |
| Pfizer INC. | $216.02 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $213.69 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $187.33 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $160.21 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.48 | 2022-2023 | |
| Cvrx, INC. | $124.66 | 2024-2025 | Barostim Neo System |
| Penumbra, INC. | $117.49 | 2024 | Indigo System |
| Lantheus Medical Imaging, INC. | $106.54 | 2023 | Definity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $89.58 | 2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $86.90 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $72.91 | 2019 | |
| Medtronic, INC. | $50.77 | 2024 | Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $27.97 | 2023 | Eliquis, Camzyos |
| Novo Nordisk INC | $27.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.